Eli Lilly And Co (NYSE: LLY) faced a setback following the release of top-line results from a late-stage study of its pain medication candidate.  What Happened Lilly and partner Pfizer Inc. (NYSE: PFE) said in a Thursday news release the Phase 3 study intended to evaluate tanezumab...